Vol 4, Supplement 1 (October 2016): Annals of Translational Medicine

Editorial

The hunt for fatal myocardial infarction biomarkers: predictive circulating microRNAs
Francesco Russo, Milena Rizzo, Kirstine Belling, Søren Brunak, Lasse Folkersen
Annals of Translational Medicine
 2016;
4
(1)
:1
Acquisition of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: just a question of time?
Ahmed Elkalioubie, Saad Nseir
Annals of Translational Medicine
 2016;
4
(1)
:2
Another promise against ischemia reperfusion injury: every success raises new questions
Dennis V. Cokkinos Dennis V. Cokkinos
Annals of Translational Medicine
 2016;
4
(1)
:3
Live-attenuated vaccination increases the diversity of pathogen-specific T cell repertoire triggered in chronic infection responses
Alexandre Morrot
Annals of Translational Medicine
 2016;
4
(1)
:4
Immunotherapy in small-cell lung cancer: at what point are we?
Antonio Rossi
Annals of Translational Medicine
 2016;
4
(1)
:5
Is macitentan not a treatment option for digital ulcers in systemic sclerosis?
Yoshihide Asano
Annals of Translational Medicine
 2016;
4
(1)
:6
The AMPK-SKP2-CARM1 axis links nutrient sensing to transcriptional and epigenetic regulation of autophagy
Ziheng Xu, Daniel J. Klionsky
Annals of Translational Medicine
 2016;
4
(1)
:7
Sofosbuvir and velpatasvir: a stellar option for patients with decompensated hepatitis C virus (HCV) cirrhosis
Joel V. Chua, Shyam Kottilil
Annals of Translational Medicine
 2016;
4
(1)
:8
Immune checkpoint inhibition in patients with brain metastases
Tanner Johanns, Saiama N. Waqar, Daniel Morgensztern
Annals of Translational Medicine
 2016;
4
(1)
:9
Osteoporosis and strontium-substituted hydroxyapatites
Nikolaos Kourkoumelis
Annals of Translational Medicine
 2016;
4
(1)
:10
Na+ homeostasis by epithelial Na+ channel (ENaC) and Nax channel (Nax): cooperation of ENaC and Nax
Yoshinori Marunaka, Rie Marunaka, Hongxin Sun, Toshiro Yamamoto, Narisato Kanamura, Akiyuki Taruno
Annals of Translational Medicine
 2016;
4
(1)
:11
C-WORTHY: the beginning of the rise of elbasvir and grazoprevir for the treatment of hepatitis C genotype 1 mono and HIV co-infected patients
Dost Sarpel, Douglas T. Dieterich
Annals of Translational Medicine
 2016;
4
(1)
:12
Grazoprevir plus elbasvir and other treatment options in hepatitis C infected patients with stage 4–5 chronic kidney disease
Kalyan Ram Bhamidimarri
Annals of Translational Medicine
 2016;
4
(1)
:13
ASSURE vs. S-TRAC: conflicting results of adjuvant treatments for kidney cancer in the era of targeted agents and genomics
Camillo Porta, Silvia Chiellino
Annals of Translational Medicine
 2016;
4
(1)
:14
A liberal glycemic target in critically ill patients with poorly controlled diabetes?
Jan Gunst, Greet Van den Berghe
Annals of Translational Medicine
 2016;
4
(1)
:15
Can xerostomia be further reduced by sparing parotid stem cells?
Avraham Eisbruch
Annals of Translational Medicine
 2016;
4
(1)
:16
Transapical beating-heart mitral valve repair using a cordal implantation device—are we ready to open our minds?
Talal Al-Atassi, Vinod H. Thourani
Annals of Translational Medicine
 2016;
4
(1)
:17
The role of glutamate transport and SLC7A11 expression in tumor-associate seizures and survival in patients with malignant gliomas
Joseph R. Keen, Sharon A. Swanger, Stephen F. Traynelis, Jeffrey J. Olson
Annals of Translational Medicine
 2016;
4
(1)
:18
Modifying therapy in patients with advanced Hodgkin’s lymphoma by integrating early metabolic response by interim PET-CT
Ulrike Bacher, Mascha Binder
Annals of Translational Medicine
 2016;
4
(1)
:19
A canine model for neuronal ceroid lipofuscinosis highlights the promise of gene therapy for lysosomal storage diseases
Jonathan E. Phillips, Richard H. Gomer
Annals of Translational Medicine
 2016;
4
(1)
:20
The Ross procedure is under-used although long-term results show superior results to those obtained following mechanical aortic valve replacement
Thierry Carrel
Annals of Translational Medicine
 2016;
4
(1)
:21
Hospital-acquired pneumonia and community-acquired pneumonia: two guys?
Thomas Tschernig
Annals of Translational Medicine
 2016;
4
(1)
:22
Connecting enterovirus infection to dystrophin dysfunction in dilated cardiomyopathy
Qiongling Wang, Xander H. T. Wehrens
Annals of Translational Medicine
 2016;
4
(1)
:23
Tumor vaccines and cellular immunotherapies
John Nemunaitis, Neil Senzer, Leah Plato
Annals of Translational Medicine
 2016;
4
(1)
:24
Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?
Alberto Dominguez-Rodriguez
Annals of Translational Medicine
 2016;
4
(1)
:25
The case for preoperative aspirin administration in patients undergoing elective CABG: is it open or closed?
Regina Kayse, Richard C. Becker
Annals of Translational Medicine
 2016;
4
(1)
:26
Interventional therapies in ischemic ventricular dysfunction: facts and versions!
Paulo Cury Rezende, Diogo Freitas Cardoso de Azevedo, Whady Hueb
Annals of Translational Medicine
 2016;
4
(1)
:27
Towards a cure for Fibrodysplasia ossificans progressiva
Gonzalo Sanchez-Duffhues, David J. J. de Gorter, Peter ten Dijke
Annals of Translational Medicine
 2016;
4
(1)
:28
Narcolepsy and influenza vaccination—the inappropriate awakening of immunity
Anoma Nellore, Troy D. Randall
Annals of Translational Medicine
 2016;
4
(1)
:29
Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury
Johannes Mair
Annals of Translational Medicine
 2016;
4
(1)
:30

Commentary

Afatinib plus chemotherapy versus chemotherapy alone after progression on afatinib: new insights on old question?
Priyanka Bhateja, Neelesh Sharma
Annals of Translational Medicine
 2016;
4
(1)
:31
Rhythm is a dancer: the immediate management of postoperative atrial fibrillation following cardiac surgery
Martin I. Sigurdsson, Simon C. Body
Annals of Translational Medicine
 2016;
4
(1)
:32
Branching pattern of the lateral femoral cutaneous nerve at the proximal thigh: a commentary on a recent published cadaveric study
Yasuhiro , Homma, Yu Ozaki
Annals of Translational Medicine
 2016;
4
(1)
:33
Continuing aspirin before coronary artery bypass grafting surgery: old fears challenged by new evidences
Massimo Chello, Antonio Nenna
Annals of Translational Medicine
 2016;
4
(1)
:34
The prostate-specific protein, transglutaminase 4 (TG4), is an autoantigen associated with male subfertility
Siiri E. Iismaa
Annals of Translational Medicine
 2016;
4
(1)
:35
Should trochanteric osteotomy be always avoided during safe hip dislocation?
Alessandro Aprato, Chiara Baroni, Alessandro Massè
Annals of Translational Medicine
 2016;
4
(1)
:36
The anterolateral ligament: a closed chapter?
Willem A. Kernkamp, Guoan Li, Samuel K. Van de Velde
Annals of Translational Medicine
 2016;
4
(1)
:37
Circulating fibrocytes serve as a marker for clinical diagnosis
Thuy Cao, Sheeja Rajasingh, Johnson Rajasingh
Annals of Translational Medicine
 2016;
4
(1)
:38
Robotics accuracy in orthopaedics: is it enough for a well-working knee replacement?
Francesco Mancuso, Hemant Pandit
Annals of Translational Medicine
 2016;
4
(1)
:39
Robotic unicondylar knee arthroplasty: a commentary on a recently published level 1 study
Alexander H. Jinnah, Ashley Multani, Riyaz H. Jinnah, Johannes F. Plate
Annals of Translational Medicine
 2016;
4
(1)
:40
The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies
Jennifer L. Wilkinson-Berka, Devy Deliyanti
Annals of Translational Medicine
 2016;
4
(1)
:41
The emerging role of sST2 blocking in the therapy of graft-versus-host disease
Yifan Xiao, Fang Zheng
Annals of Translational Medicine
 2016;
4
(1)
:42
Time to progression ratio: promising new metric or just another metric?
Ming-Wen An, Sumithra J. Mandrekar
Annals of Translational Medicine
 2016;
4
(1)
:43
PTK2/FAK: a new predictive biomarker for response to radiotherapy in head and neck squamous cell carcinoma
Emma J. de Ruiter, Stefan M. Willems
Annals of Translational Medicine
 2016;
4
(1)
:44
Azoramide: a new drug for the treatment of type 2 diabetes?
Carlos Guillen
Annals of Translational Medicine
 2016;
4
(1)
:45
Severe ischemic cardiomyopathy—a new answer in management?
Brian C. Case, Monvadi B. Srichai
Annals of Translational Medicine
 2016;
4
(1)
:46
Vasopressin versus noradrenaline as initial therapy in septic shock. Is vasopressin-related renal protection doomed to “vanish” in the haze?
Patrick M. Honore, Rita Jacobs, Elisabeth De Waele, Inne Hendrickx, Herbert D. Spapen
Annals of Translational Medicine
 2016;
4
(1)
:47
Statins barely touch the heart but bite the kidneys after cardiac surgery. Coenzyme Q10 deficiency in the dock?
Patrick M. Honore, Rita Jacobs, Inne Hendrckx, Herbert D. Spapen
Annals of Translational Medicine
 2016;
4
(1)
:48
Less invasive approach in knee arthroplasty: everybody on board?
Guilherme Moreira Abreu-e-Silva, Thiago Scherr Dias, Marco Antônio Percope de Andrade
Annals of Translational Medicine
 2016;
4
(1)
:49
Collagen and fibronectin: threads linking obesity and breast cancer
Lesley G. Ellies
Annals of Translational Medicine
 2016;
4
(1)
:50
Playing with nanoparticle shapes and laser powers to decide which route to take during photothermal therapy: apoptosis or necrosis?
Claudia Tortiglione, Roberta Iachetta
Annals of Translational Medicine
 2016;
4
(1)
:51
Hybrid approach to multivessel coronary artery disease: a commentary
Alberto Repossini
Annals of Translational Medicine
 2016;
4
(1)
:52
Rational for targeting the hedgehog signalling pathway in acute myeloid leukemia with FLT3 mutation
Didier Bouscary
Annals of Translational Medicine
 2016;
4
(1)
:53
Magnetic resonance imaging-guided stratified selection of patients for nano-therapy
Zhen Zheng, Gaolin Liang
Annals of Translational Medicine
 2016;
4
(1)
:54
Ischemia-reperfusion injury: evidences for translational research
Francesco Bellanti
Annals of Translational Medicine
 2016;
4
(1)
:55
Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapies
Amy S. Codd, Saly Al-Taei, Zsuzsanna Tabi
Annals of Translational Medicine
 2016;
4
(1)
:56
A sensible approach to targeting STAT3-mediated transcription
Neil E. Bhola, Daniel E. Johnson, Jennifer R. Grandis
Annals of Translational Medicine
 2016;
4
(1)
:57
Preclinical randomized controlled multicenter trials in translational stroke research
Sergio Amaro, Laura Llull
Annals of Translational Medicine
 2016;
4
(1)
:58
Th2/Th17 reciprocal regulation: twists and turns in the complexity of asthma phenotypes
Jason P. Lynch, Manuel A. Ferreira, Simon Phipps
Annals of Translational Medicine
 2016;
4
(1)
:59
Circulating extracellular vesicles containing miRNAs may have utility as early biomarkers for cardiac injury
Bethany Doran, Deepak Voora
Annals of Translational Medicine
 2016;
4
(1)
:60
Precision medicine with electronic medical records: from the patients and for the patients
Losiana Nayak, Indrani Ray, Rajat K. De
Annals of Translational Medicine
 2016;
4
(1)
:61
Epidermal growth factor as a prognostic biomarker in chronic kidney diseases
Yoshitaka Isaka
Annals of Translational Medicine
 2016;
4
(1)
:62
Therapeutic illusion: another frontier in Ménière’s disease
Nicolas Pérez-Fernández, Eduardo Martín-Sanz
Annals of Translational Medicine
 2016;
4
(1)
:63
Application of liquid biopsies to identify genomic factors associated with therapy resistance in castration resistant prostate cancer
Daniel J. Crona, Young E. Whang
Annals of Translational Medicine
 2016;
4
(1)
:64
Second line treatment of small cell lung cancer: more is better?
Michael S. Humeniuk, Michael John Kelley
Annals of Translational Medicine
 2016;
4
(1)
:65
Has moderate ischemic mitral regurgitation to be corrected?—Analysis of a randomized trial
Antonio Maria Calafiore, Sotiris Prapas, Walid Abukoudair, Michele Di Mauro
Annals of Translational Medicine
 2016;
4
(1)
:66
Did the beneficial renal outcomes with vasopressin VANISH?
Gretchen L. Sacha, Simon W. Lam, Seth R. Bauer
Annals of Translational Medicine
 2016;
4
(1)
:67
The state of the art in prediction of breast cancer relapse using cell-free circulating tumor DNA liquid biopsies
Niklas Loman, Lao H. Saal
Annals of Translational Medicine
 2016;
4
(1)
:68

Disclosure:

The supplement was published without any sponsorship or funding.